Monitoring of a Patient Who Is on a Lipid-Lowering Drug

question 3

Multiple Choice

Monitoring of a patient who is on a lipid-lowering drug includes:

• A) Fasting total cholesterol every 6 months
• B) Lipid profile with attention to serum LDL 6 to 8 weeks after starting therapy then again in 6 weeks
• C) Complete blood count,CRP,and ESR after 6 weeks of therapy
• D) All of the above

---

Definitions:

Agoraphobia

The fear of places and situations that might cause panic, helplessness, or embarrassment.

Social Anxiety Disorder

A chronic mental health condition characterized by an intense fear of social situations due to perceived negative evaluation by others.

Specific Phobia

An intense, irrational fear of a specific object, activity, or situation that leads to significant distress or impairment in social, occupational, or other important areas of functioning.

Anxiety

A feeling of worry, nervousness, or unease, typically about an imminent event or something with an uncertain outcome.